Physician profile
David Lind
NPI 1548278161
$1,411.02
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $337 · 2021: $377 · 2022: $420 · 2023: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $442.01 | 2020-2022 | |
| Hologic INC | $251.52 | 2021 | |
| W. L. Gore & Associates, INC. | $139.41 | 2023 | Gore Synecor Biomaterial |
| Conmed Corporation | $110.20 | 2022 | |
| Kci USA, INC. | $108.13 | 2023 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Integra Lifesciences Corporation | $83.49 | 2021-2022 | |
| Intuitive Surgical, INC. | $69.66 | 2022 | |
| Merck Sharp & Dohme LLC | $62.26 | 2022 | |
| Ethicon US, LLC | $53.19 | 2021-2022 | |
| Covidien Lp | $31.92 | 2020 | |
| Axogen | $29.87 | 2021 | |
| Medtronic, INC. | $29.36 | 2023 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.